Sanofi

Introducing the First Treatment Option for Paediatric and Adult Patients with Primary HLH

by Sanofi Genzyme. with support from Redline Strategic. ... Transforming the Rare Disease Sales Call - by Sanofi Genzyme.

Takeda UK’s Launch of Takhzyro

by Sanofi Genzyme. with support from Lucid Group. ... A Licensed Systemic Therapy for Advanced Cutaneous Squamous-Cell Carcinoma - by Sanofi Genzyme.

Building a brighter future for rare disease patients

As sponsors of the category, we are delighted to play a part in recognising the outstanding work of Abbvie, Boehringer Ingelheim, Jazz, Merck, Sanofi Genzyme and the Cambridge Rare Disease Network.

Sanofi’s quadrivalent flu vaccine Supemtek scores EU approval

Sanofi’s Supemtek is the now first and only recombinant influenza vaccine to be approved within the European Union. ... In addition to the GSK partnership, Sanofi also signed an agreement with Translate Bio to develop an mRNA-based COVID-19 vaccine.

AZ’s COVID-19 vaccine proves promising in elderly participants, new data shows

The UK has also secured doses of Pfizer/BioNTech’s COVID-19 vaccine, as well as potential vaccines from Valneva, Sanofi/GlaxoSmithKline, Moderna, Novavax and Johnson &Johnson.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]